Insider Trading & Ownership - Rowland Charles A Jr

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Rowland Charles A Jr
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-12-01
Purchase
2023-12-05
4:30 pm
Generation Bio Co.GBIORowland Charles A Jr
Director
342,960$1.3931$477,778534,757
(Direct)
View
2023-05-16
Sale
2023-05-18
6:31 pm
Viking Therapeutics Inc.VKTXRowland Charles A Jr
Director
40,000$25$1,000,00030,000
(Direct)
View
2022-09-19
Purchase
2022-09-20
4:16 pm
Generation Bio Co.GBIORowland Charles A Jr
Director
15,750$5.26$82,845191,797
(Direct)
View
2022-09-15
Purchase
2022-09-19
5:21 pm
Generation Bio Co.GBIORowland Charles A Jr
Director
50,628$5.4563$276,241176,047
(Direct)
View
2022-09-13
Purchase
2022-09-15
4:07 pm
Generation Bio Co.GBIORowland Charles A Jr
Director
24,384$5.2249$127,404125,419
(Direct)
View
2022-08-01
Sale
2022-08-03
9:48 pm
Nabriva Therapeutics plcNBRVRowland Charles A Jr
Director
8,496$0.175$1,48715,277
(Direct)
View
2021-08-02
Sale
2021-08-04
9:05 pm
Nabriva Therapeutics plcNBRVRowland Charles A Jr
Director
777$1.2$93223,773
(Direct)
View
2021-01-11
Purchase
2021-01-13
4:04 pm
Generation Bio Co.GBIORowland Charles A Jr
Director
20,408$24.5$499,996101,035
(Direct)
View
2020-12-17
Sale
2020-12-18
4:09 pm
Blueprint Medicines CorpBPMCRowland Charles A Jr
Director
10,909$117.82$1,285,2983,562
(Direct)
View
2020-11-02
Sale
2020-11-04
5:18 pm
Blueprint Medicines CorpBPMCRowland Charles A Jr
Director
10,000$98.9$989,0119,084
(Direct)
View
2020-06-16
Purchase
2020-06-18
5:30 pm
Generation Bio Co.GBIORowland Charles A Jr
Director
30,000$19$570,00080,627
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-06
Option Award
2024-06-10
4:05 pm
N/A
2034-06-05
Generation Bio Co.GBIORowland Charles A Jr
Director
60,000$060,000
(Direct)
View
2024-01-24
Disposition
2024-01-24
5:25 pm
N/A
2032-06-06
Orchard Therapeutics plcORTXRowland Charles A Jr
Director
163,294$00
(Direct)
View
2024-01-02
Option Award
2024-01-04
9:27 pm
2025-01-02
2034-01-02
Viking Therapeutics Inc.VKTXRowland Charles A Jr
Director
32,000$032,000
(Direct)
View
2023-06-14
Option Award
2023-06-16
4:30 pm
N/A
2033-06-13
Orchard Therapeutics plcORTXRowland Charles A Jr
Director
105,000$0105,000
(Direct)
View
2023-06-08
Option Award
2023-06-12
4:15 pm
N/A
2033-06-07
Generation Bio Co.GBIORowland Charles A Jr
Director
25,000$025,000
(Direct)
View
2023-05-16
Exercise
2023-05-18
6:31 pm
N/A
N/A
Viking Therapeutics Inc.VKTXRowland Charles A Jr
Director
40,000$1.0830,000
(Direct)
View
2023-05-16
Exercise
2023-05-18
6:31 pm
2018-07-01
2027-07-01
Viking Therapeutics Inc.VKTXRowland Charles A Jr
Director
40,000$030,000
(Direct)
View
2023-01-03
Option Award
2023-01-04
6:12 pm
2024-01-03
2033-01-03
Viking Therapeutics Inc.VKTXRowland Charles A Jr
Director
22,000$022,000
(Direct)
View
2022-06-09
Option Award
2022-06-13
4:05 pm
N/A
2032-06-08
Generation Bio Co.GBIORowland Charles A Jr
Director
19,200$019,200
(Direct)
View
2022-06-07
Option Award
2022-06-08
4:05 pm
N/A
2032-06-06
Orchard Therapeutics plcORTXRowland Charles A Jr
Director
46,000$046,000
(Direct)
View
2022-01-03
Option Award
2022-01-05
7:11 pm
2023-01-03
2032-01-03
Viking Therapeutics Inc.VKTXRowland Charles A Jr
Director
22,000$022,000
(Direct)
View
2021-07-28
Option Award
2021-07-30
8:21 pm
N/A
2031-07-28
Nabriva Therapeutics plcNBRVRowland Charles A Jr
Director
52,500$059,550
(Direct)
View
2021-06-16
Option Award
2021-06-17
5:02 pm
N/A
2031-06-15
Orchard Therapeutics plcORTXRowland Charles A Jr
Director
40,000$040,000
(Direct)
View
2021-06-09
Option Award
2021-06-11
4:09 pm
N/A
2031-06-08
Generation Bio Co.GBIORowland Charles A Jr
Director
15,000$015,000
(Direct)
View
2021-06-02
Option Award
2021-06-04
4:16 pm
N/A
2031-06-02
Blueprint Medicines CorpBPMCRowland Charles A Jr
Director
6,750$010,312
(Direct)
View
2021-01-04
Option Award
2021-01-06
4:42 pm
2022-01-04
2031-01-04
Viking Therapeutics Inc.VKTXRowland Charles A Jr
Director
22,000$022,000
(Direct)
View
2020-12-17
Exercise
2020-12-18
4:09 pm
N/A
2026-06-23
Blueprint Medicines CorpBPMCRowland Charles A Jr
Director
10,909$03,562
(Direct)
View
2020-12-17
Exercise
2020-12-18
4:09 pm
N/A
N/A
Blueprint Medicines CorpBPMCRowland Charles A Jr
Director
10,909$19.533,562
(Direct)
View
2020-11-02
Exercise
2020-11-04
5:18 pm
N/A
2025-03-22
Blueprint Medicines CorpBPMCRowland Charles A Jr
Director
10,000$09,084
(Direct)
View
2020-11-02
Exercise
2020-11-04
5:18 pm
N/A
N/A
Blueprint Medicines CorpBPMCRowland Charles A Jr
Director
10,000$9.469,084
(Direct)
View
2020-07-29
Option Award
2020-07-31
4:55 pm
N/A
2030-07-28
Nabriva Therapeutics plcNBRVRowland Charles A Jr
Director
52,500$0105,500
(Direct)
View
2020-06-24
Option Award
2020-06-26
4:10 pm
N/A
2030-06-24
Blueprint Medicines CorpBPMCRowland Charles A Jr
Director
6,750$08,062
(Direct)
View
2020-06-19
Exercise
2020-06-23
4:15 pm
N/A
N/A
Blueprint Medicines CorpBPMCRowland Charles A Jr
Director
1,312$01,312
(Direct)
View
2020-06-17
Option Award
2020-06-19
4:18 pm
N/A
2030-06-16
Orchard Therapeutics plcORTXRowland Charles A Jr
Director
35,000$035,000
(Direct)
View
2020-06-16
Conversion
2020-06-18
5:30 pm
N/A
N/A
Generation Bio Co.GBIORowland Charles A Jr
Director
140,050$080,627
(Direct)
View
2020-06-11
Option Award
2020-06-15
5:24 pm
N/A
2030-06-10
Generation Bio Co.GBIORowland Charles A Jr
Director
52,000$052,000
(Direct)
View

Ownership
2020-06-11
8:35 pm
N/A
N/A
Generation Bio Co.GBIORowland Charles A Jr
Director
0$093,088
(Direct)
View
2020-01-02
Option Award
2020-01-03
7:55 pm
2021-01-02
2030-01-02
Viking Therapeutics Inc.VKTXRowland Charles A Jr
Director
22,000$022,000
(Direct)
View

Ownership
2020-01-02
4:18 pm
N/A
N/A
Orchard Therapeutics plcORTXRowland Charles A Jr
Director
0$0127,324
(Direct)
View